Evidence map›Paper›PMID 27263971›Full record

ArticleNeuron2016

Sensory-Derived Glutamate Regulates Presynaptic Inhibitory Terminals in Mouse Spinal Cord.

Michael Mende, Emily V Fletcher, Josephine L Belluardo, Joseph P Pierce, Praveen K Bommareddy, Jarret A Weinrich, Zeeba D Kabir, Kathryn C Schierberl, John G Pagiazitis, Alana I Mendelsohn and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuron, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Activity of spinal RORβ neurons is related to functional improvements following combination treatment after complete SCI.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Molecular and Cellular Mechanisms of Motor Circuit Development.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Stabilization of Spine Synaptopodin by mGluR1 Is Required for mGluR-LTD.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  15. Review
  16. Proprioception revisited: where do we stand?Current opinion in physiology · 2021
    Article
  17. Spinal Inhibitory Interneurons: Gatekeepers of Sensorimotor Pathways.International journal of molecular sciences · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 1 country.

Michael MendeDevelopmental Biology Program, Sloan Kettering Institute, New York, NY 10065, USA.
Emily V FletcherDepartment of Pathology and Cell Biology and Department of Neurology, Columbia University, New York, NY 10032, USA; Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA.
Josephine L BelluardoDevelopmental Biology Program, Sloan Kettering Institute, New York, NY 10065, USA; Neuroscience Program, Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY 10065, USA.
Joseph P PierceFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA.
Praveen K BommareddyDevelopmental Biology Program, Sloan Kettering Institute, New York, NY 10065, USA.
Jarret A WeinrichDevelopmental Biology Program, Sloan Kettering Institute, New York, NY 10065, USA; Biochemistry, Cell and Molecular Biology Program, Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY 10065, USA.
Zeeba D KabirFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA; Department of Pediatrics, Division of Pediatric Neurology, Weill Cornell Medicine, New York, NY 10065, USA.
Kathryn C SchierberlFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA; Department of Pediatrics, Division of Pediatric Neurology, Weill Cornell Medicine, New York, NY 10065, USA.
John G PagiazitisDepartment of Pathology and Cell Biology and Department of Neurology, Columbia University, New York, NY 10032, USA; Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA.
Alana I MendelsohnHoward Hughes Medical Institute, Kavli Institute for Brain Science, Zuckerman Mind Brain Behavior Institute, Department of Neuroscience and Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA.
Anna FrancesconiDominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Robert H EdwardsDepartment of Neurology and Department of Physiology, Graduate Programs in Neuroscience and Cell Biology, UCSF School of Medicine, San Francisco, CA 94143, USA.
Teresa A MilnerFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA; Harold and Margaret Milliken Hatch Laboratory of Neuroendocrinology, The Rockefeller University, New York, NY 10065, USA.
Anjali M RajadhyakshaFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA; Department of Pediatrics, Division of Pediatric Neurology, Weill Cornell Medicine, New York, NY 10065, USA.
Peter J van RoesselDepartment of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
George Z MentisDepartment of Pathology and Cell Biology and Department of Neurology, Columbia University, New York, NY 10032, USA; Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA. Electronic address: gzmentis@columbia.edu.
Julia A KaltschmidtDevelopmental Biology Program, Sloan Kettering Institute, New York, NY 10065, USA; Neuroscience Program, Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY 10065, USA; Biochemistry, Cell and Molecular Biology Program, Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY 10065, USA. Electronic address: kaltschj@mskcc.org.
Cornell University · USColumbia University Irving Medical Center · USKettering University · USAlbert Einstein College of Medicine · USColumbia University · USHoward Hughes Medical Institute · USUniversity of California, San Francisco · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Radiotelemetry CoreP01HL096571 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI DAVISSON, ROBIN L · 2009 to 2013
$8.8M
Mechanisms of Central Synaptic Dysfunction in SMAR01NS078375 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI George Z Mentis · 2012 to 2026
$6.6M
ULTRASTRUCTURAL INTERACTIONS OF OPIOIDS IN HIPPOCAMPUSR01DA008259 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI MILNER, TERESA A · 1993 to 2019
$6.4M
PHARMACOLOGY AND NEUROSCIENCE OF DRUG ABUSET32DA007274 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI SZETO, HAZEL H · 1991 to 2011
$4.8M
Molecular Mechanisms Regulating Inhibitory Circuitry in the Spinal CordR01NS083998 · NINDS · STANFORD UNIVERSITY · PI KALTSCHMIDT, JULIA ANNA · 2013 to 2023
$3.6M
Transport of Neurotransmitter Into Synaptic VesiclesR37MH050712 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EDWARDS, ROBERT H · 2012 to 2020
$3.5M
Training Program in Developmental BiologyT32HD060600 · NICHD · WEILL MEDICAL COLL OF CORNELL UNIV · PI BAO, ZHIRONG, STUHLMANN, HEIDI · 2010 to 2024
$3.5M
The Role of Cav1.2 L-type Ca2+ Channels in Cocaine-Induced ReinstatementR01DA029122 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI RAJADHYAKSHA, ANJALI M · 2012 to 2016
$2.1M
Regulation of Metabotropic glutamate Receptor Signaling by Caveolar RaftsR01MH082870 · NIMH · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI FRANCESCONI, ANNA · 2009 to 2013
$2.0M
MENOPAUSAL CHANGES IN HYPOTHALAMUS AND HYPERTENSION SUSCEPTIBILITYR01HL098351 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MILNER, TERESA A · 2011 to 2014
$1.7M
NCI NIH HHS P30 CA008748NHLBI NIH HHS P01 HL096571NHLBI NIH HHS R01 HL098351NICHD NIH HHS T32 HD060600NIDA NIH HHS R01 DA008259NIDA NIH HHS R01 DA029122NIDA NIH HHS T32 DA007274NIMH NIH HHS R01 MH082870NIMH NIH HHS R37 MH050712NINDS NIH HHS R01 NS078375NINDS NIH HHS R01 NS083998
6 · The paper itself

Abstract

Circuit function in the CNS relies on the balanced interplay of excitatory and inhibitory synaptic signaling. How neuronal activity influences synaptic differentiation to maintain such balance remains unclear. In the mouse spinal cord, a population of GABAergic interneurons, GABApre, forms synapses with the terminals of proprioceptive sensory neurons and controls information transfer at sensory-motor connections through presynaptic inhibition. We show that reducing sensory glutamate release results in decreased expression of GABA-synthesizing enzymes GAD65 and GAD67 in GABApre terminals and decreased presynaptic inhibition. Glutamate directs GAD67 expression via the metabotropic glutamate receptor mGluR1β on GABApre terminals and regulates GAD65 expression via autocrine influence on sensory terminal BDNF. We demonstrate that dual retrograde signals from sensory terminals operate hierarchically to direct the molecular differentiation of GABApre terminals and the efficacy of presynaptic inhibition. These retrograde signals comprise a feedback mechanism by which excitatory sensory activity drives GABAergic inhibition to maintain circuit homeostasis.

Indexed as

AnimalsBrain-Derived Neurotrophic Factorgamma-Aminobutyric AcidGlutamate DecarboxylaseGlutamic AcidInterneuronsMiceModels, NeurologicalNeural InhibitionNeuronsPresynaptic TerminalsReceptors, Metabotropic GlutamateSensory Receptor CellsSpinal CordSynapsesVesicular Glutamate Transport Protein 1Brain-Derived Neurotrophic Factorgamma-Aminobutyric AcidGlutamate Decarboxylaseglutamate decarboxylase 1glutamate decarboxylase 2Glutamic Acidmetabotropic glutamate receptor type 1Receptors, Metabotropic GlutamateSlc17a7 protein, mouseVesicular Glutamate Transport Protein 1

Identifiers

PMID27263971
PMCPMC4912012
OpenAlexW2409229481

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.